LOC145845: A Potential Drug Target and Biomarker for Neurological Disorders

LOC145845: A Potential Drug Target and Biomarker for Neurological Disorders

LOC145845 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the LOC1 family of proteins, which are known for their role in intracellular signaling.

LOC145845 has been shown to play a role in a variety of physiological processes, including cell signaling, neurotransmitter signaling, and inflammation. It has also been shown to interact with several different proteins, including the neurotransmitter GABA.

One of the most promising aspects of LOC145845 is its potential as a drug target. Because it is involved in a wide range of physiological processes, it is a promising target for the development of new treatments for a variety of neurological and psychiatric disorders.

In addition to its potential as a drug target, LOC145845 has also been shown to be a valuable biomarker for a variety of diseases. For example, it has been shown to be elevated in the brains of individuals with Alzheimer's disease, and it has been used as a biomarker for several other neurological disorders, including Parkinson's disease and multiple sclerosis.

LOC145845 is also of interest to researchers because of its structure and function. Because it is a protein that is expressed in a wide range of tissues, it is likely to have a similar structure to other proteins that are expressed in those same tissues. This could allow researchers to use techniques such as genetic engineering and protein synthesis to modify its structure and function.

Overall, LOC145845 is a protein that has the potential to be a drug target and a valuable biomarker for a variety of neurological and psychiatric disorders. Further research is needed to fully understand its role and potential.

Protein Name: Uncharacterized LOC145845

The "LOC145845 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC145845 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC148430 | LOC148696 | LOC149351 | LOC149684 | LOC151760 | LOC153893 | LOC153910 | LOC154449 | LOC154761 | LOC155060 | LOC157273 | LOC158434 | LOC158435 | LOC158696 | LOC162137 | LOC202181 | LOC221946 | LOC254896 | LOC260339 | LOC283028 | LOC283038 | LOC283045 | LOC283070 | LOC283194 | LOC283278 | LOC283299 | LOC283683 | LOC283731 | LOC283788 | LOC284009 | LOC284191 | LOC284240 | LOC284344 | LOC284379 | LOC284412 | LOC284581 | LOC284600 | LOC284788 | LOC284798 | LOC284898 | LOC284950 | LOC285097 | LOC285232 | LOC285626 | LOC285762 | LOC285819 | LOC285847 | LOC285889 | LOC286059 | LOC286083 | LOC286177 | LOC286297 | LOC286359 | LOC286437 | LOC338694 | LOC339059 | LOC339166 | LOC339260 | LOC339352 | LOC339593 | LOC339666 | LOC339685 | LOC339760 | LOC339975 | LOC340090 | LOC340184 | LOC340512 | LOC343052 | LOC344967 | LOC349160 | LOC374443 | LOC375196 | LOC387720 | LOC388242 | LOC388780 | LOC389199 | LOC389473 | LOC389765 | LOC389831 | LOC389834 | LOC389895 | LOC389906 | LOC390282 | LOC390705 | LOC391092 | LOC391343 | LOC391813 | LOC392180 | LOC392196 | LOC392232 | LOC399783 | LOC399900 | LOC400347 | LOC400464 | LOC400499 | LOC400541 | LOC400576 | LOC400622 | LOC400627 | LOC400682